Tech Company Financing Transactions
Previa Medical Funding Round
BNP Paribas, Bpifrance and Capital Croissance participated in a $2.3 million Seed funding round for Previa Medical. This venture round closed on 2/16/2023.
Transaction Overview
Company Name
Announced On
2/16/2023
Transaction Type
Venture Equity
Amount
$2,251,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to run a prospective multicenter clinical trial for SEPSI-SCORE, aimed at scientifically validating the solution to achieve two objectives: Reducing inpatient length of stays. Reducing the sepsis-mortality rate.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
38, Rue Denuzière, Lyon,
Auvergne-Rhone-Alpes, 69002
FR
Auvergne-Rhone-Alpes, 69002
FR
Phone
Undisclosed
Website
Email Address
Overview
PREVIA is an artificial intelligence capable of forecasting pathologies. Compatible with all major EHR systems using FHIR technology, it analyzes the data of thousands of patients in real time and accurately identifies the complications risks. The first score SEPSI-SCORE, MD certified in 2021, alerts up to 48 hours before the first symptoms of sepsis. Health care professionals can trigger treatment protocols earlier, reducing lengths of stay and saving lives.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Quentin Francios
Chief Technical Officer
Barthélémy Arribe
Browse more venture capital transactions:
Prev: 2/16/2023: Tangle venture capital transaction
Next: 2/16/2023: Altus Power venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC transactions reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs